The Zio ECG Utilization Software, or Zeus, system is an artificial intelligence algorithm that detects Afib and calculates an Afib burden estimate. The Zeus system can then send a report to a clinician, according to a July 22 press release.
The Zeus system algorithm will be paired with the Zio watch, the wearable component of the system, which was created through a partnership between iRhythm and Verily, an Alphabet company. The Zio watch also received FDA 510(k) clearance, according to the press release.